好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | N6 - Neuroscience in the Clinic: Functional Recovery in Neurology and Neuroscience

Wednesday 04/26/17
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Neuroscience in the Clinic Session
Deborah Hall, MD, PhD, FAAN, Massimo Pandolfo, MD, FAAN
General Neurology, Neuro-rehabilitation
Participants should become familiar with the scientific background of functional recovery after neurological damage and its potential clinical implications, including the most recent developments and future perspectives.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider
Case-based, Didactic
Event Timeline
03:30 PM - 03:40 PM Speaker Case Presentations
Brian Edlow, MD
03:30 PM - 05:30 PM Abstract 001 - Specific human antisense oligonucleotide (ASO) targeting TGF-ßRII rescues proliferation of TGF-ß arrested human neuronal progenitor cells (ReNcell CX)
Sabrina Kuespert, PhD
03:30 PM - 05:30 PM Abstract 002 - Promoting network recovery after traumatic brain injury: exploring the targeted application of transcranial direct current stimulation
Lucia M. Li
03:40 PM - 04:00 PM Speaker Neural Plasticity and Regeneration: Mechanisms and Therapeutic Strategies
Mark H. Tuszynski, MD, PhD, FAAN
04:00 PM - 04:10 PM Speaker Neural Regeneration and Repair: Clinical Perspective
Brian Edlow, MD
04:10 PM - 04:30 PM Speaker Where is the Research Heading: Latest Developments/Future Directions
04:30 PM - 04:45 PM Speaker N6.001: Specific human antisense oligonucleotide (ASO) targeting TGF-ßRII rescues proliferation of TGF-ß arrested human neuronal progenitor cells (ReNcell CX)
Sabrina Kuespert, PhD
04:45 PM - 05:00 PM Speaker N6.002: Promoting network recovery after traumatic brain injury: exploring the targeted application of transcranial direct current stimulation
Lucia M. Li
05:00 PM - 05:30 PM Speaker Panel Discussion
Faculty Disclosures
Brian Edlow, MD Dr. Edlow has received research support from NIH.
Mark H. Tuszynski, MD, PhD, FAAN No disclosure on file
Lucia M. Li The institution of Ms. Li has received research support from Academy of Medical Sciences. The institution of Ms. Li has received research support from NIHR Brain Injury Med-Tech Initiative.
Sabrina Kuespert, PhD No disclosure on file
Deborah Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Massimo Pandolfo, MD, FAAN Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities.
No disclosure on file
Ludwig Aigner, PhD No disclosure on file
Ulrich Bogdahn, MD No disclosure on file
David J. Sharp, MD No disclosure on file
Tim-Henrik Bruun, PhD No disclosure on file
Siw Johannesen, MD No disclosure on file